Chemotherapy-induced peripheral neuropathy: An unresolved issue
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is the most prevalent neurological complication of cancer treatment, affecting a third of all patients who undergo chemotherapy. CIPN impairs functional capacity, compromises the quality of life and results in dose reduction or cessatio...
Main Authors: | R. Velasco, J. Bruna |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2010-03-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580810700225 |
Similar Items
-
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
by: Renata Zajączkowska, et al.
Published: (2019-03-01) -
Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy
by: Chih-Hung Tsai, et al.
Published: (2021-08-01) -
Regulators of angiogenesis in chemotherapy-induced peripheral neuropathy
by: Vladimir V. Bazarnyi, et al.
Published: (2022-12-01) -
Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy
by: Fumiko Sekiguchi, et al.
Published: (2020-12-01) -
Chemotherapy-induced peripheral neuropathy: a literature review
by: Lelia Gonçalves Rocha Martin, et al.
Published: (2011-12-01)